AJMC Staff

Fears of health insurance premium hikes during the third year of the Affordable Care Act may not be unfounded. In Tennessee, the state's insurance commissioner just approved BlueCross BlueShield of Tennessee's 36.3% increase.

Alaska Governor Bill Walker (I) announced in July that he would expand Medicaid in his state despite the legislature's decision to block his efforts, and now the Republican-controlled body is suing him.

Semaglutide is currently available as an injectible only, but the company is working on a once-daily pill form.

A prominent neuroscientist has developed the Quick Dementia Rating System to reliably, and quickly, identify patients suffering from dementia.

States that are unable to accelerate their efforts to slow Medicaid spending will face long-term budget imbalances, according to a new report from Fitch Ratings.

An immunotherapy developed by Amgen and approved by the FDA for the treatment of acute lymhoblastic leukemia in December 2014 has now received coverage assurance from Medicare, following an initial rejection.

The approach for assessing hospital penalties under the Hospital-Acquired Condition Reduction Program might need to be reconsidered in order to achieve the intended goal of the program.

The network, PEDSnet, combines big data from electronic health records with family engagement

Households that received financial help for health insurance under the Affordable Care Act are now having tax return issues, which could jeopardize their eligibility for subsidies next year.

Safety net hospitals in California are using a car manufacturer's model to improve efficiency while saving on care costs.

Patient safety is often at risk during the emergency department to inpatient physician handoff process, which can be subject to complex challenges.

Telemedicine could increase access to best-practice care for older adults with major depression who are facing barriers of mobility, stigma, and geographical isolation, and a study published in The Lancet Psychiatry compared treatment response delivered via telemedicine with same-room care.

In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding and there are 3 ways to measure performance in patient-centered outcomes research.

The study found that the geriatric population in the United States receives prescriptions for mental health drugs at more than twice the rate that younger adults do, but they present a lower rate of seeking psychiatric care.

Increasing health insurance enrollment is only one part of the goal of the Affordable Care Act-the law also aims to improve population health and lower healthcare costs, but less attention has been paid to these critical steps.

Drug manufacturers often fail to stick to the 15-day timeframe of reporting serious adverse events to the FDA, a new study in JAMA Internal Medicine reports.

There is a link between low-value prescribing and graduate medical training, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published in the Journal of General Internal Medicine.

The high cost of running a state-based health insurance exchanges created under the Affordable Care Act could lead to states turning over operations to the federal government or joining forces with other states.

A study published in Nature Medicine has identified a gene signature that can predict cancer patient outcomes across a wide spectrum of malignancies.

A study in JAMA Oncology has found that chemotherapy for patients with end-stage cancer was associated with worse quality of life near death while they still retained their ability to perform many life functions.

The findings have policy importance in the developing world, where low birth weight is often followed by rapid transition to Western lifestyles.

Zarxio (filgrastim-sndz), manufactured by Sandoz as a biosimilar to Amgen's Neupogen, has finally received marketing approval from a federal appeals court.

A new program from the Institute for Clinical and Economic Review will produce public reports that include a full analysis of the comparative effectiveness, the cost-effectiveness, and the potential budget impact of new drugs.

The study, published in the Annals of Internal Medicine, examined antibiotic prescribing pratices within the Department of Veterans Affairs.

The American Society of Clinical Oncology has issued a position statement in the Journal of Clinical Oncology, calling for federal agencies and the cancer research community to broaden clinical trials to include older adults.

Instead of making patients suffering from life-limiting illnesses choose between hospice care and curative care, CMS will test coverage that allows individuals to receive palliative and curative treatment concurrently.

Nivolumab proved superior to everolimus in improving overall survival in previously treated patients.

A new blog post at RAND argues that Medicare's plans to reimburse providers for advance care planning has been a long time coming.

The demand for oral parity for oncology medications is back up for vote in the Senate in North Carolina.

The Annual Report to the Nation on Status of Cancer, product of a collaboration between The American Cancer Society, Centers for Disease Control and Prevention, National Cancer Institute, and North American Association of Central Cancer Registries, has been published.